“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”
Document Type
News Article
Publication Date
8-1-2023
Keywords
washington; spokane; prmc
Clinical Institute
Kidney & Diabetes
Specialty/Research Institute
Endocrinology
Specialty/Research Institute
Nephrology
Comments
Pharmacy Times